🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether SF2a-TT15 (a monovalent s...
Status
Completed
Location
University of Maryland, Baltimore, Center for Vaccine Development and Global Health
Start Date
2020-03-02
Trial ID
NCT04078022
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and immunogen...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-08-29
Trial ID
NCT03527173
Treatments Being Tested
The purpose of this study is to determine whether CVD 1208S (a live, attenu...
Status
Terminated
Location
University of Maryland, Baltimore Center for Vaccine Development
Start Date
2010-01
Trial ID
NCT00866476
Treatments Being Tested
The goal of this study is to better understand Shigella immunity. The study...
Status
Completed
Location
Center for Immunization Research (CIR) at Johns Hopkins School of Public Health (JHSPH)
Start Date
2022-04-26
Trial ID
NCT04992520
Treatments Being Tested
The purpose of this study is to determine whether CVD 1208S (a live, attenu...
Status
Terminated
Location
Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility
Start Date
2010-01
Trial ID
NCT00866242
Treatments Being Tested
This is a trial to evaluate the safety, reactogenicity, immunogenicity and ...
Status
Completed
Location
The Hope Clinic of Emory University
Start Date
2022-10-12
Trial ID
NCT04242264
Treatments Being Tested
The purpose of this study is to select a safe and immunogenic dose of Invap...
Status
Completed
Location
Center for Immunization Research (CIR) John Hopkins Bayview Medical Center
Start Date
2007-05
Trial ID
NCT00485134
Development of an S. sonnei human challenge model using a newly manufacture...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2016-09-12
Trial ID
NCT02816346
Treatments Being Tested